U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

U.S. Food and Drug Administration
  1. Home
  2. Drugs
  3. Drug Safety and Availability
  4. Information by Drug Class
  5. Drug Treatments for Asthma and Chronic Obstructive Pulmonary Disease that Do Not Use Chlorofluorocarbons
  1. Information by Drug Class

Drug Treatments for Asthma and Chronic Obstructive Pulmonary Disease that Do Not Use Chlorofluorocarbons

Many inhalers that do not use chlorofluorocarbons (CFC) are already available for the treatment of asthma and chronic obstructive pulmonary disease. These products aren't necessarily "official" direct alternatives to CFC Metered Dose Inhalers, but may in many patients serve as a useful medication that could replace the need for a particular CFC Metered Dose Inhaler. FDA will determine official alternatives by using the criteria established through notice-and-comment rulemaking, as it has done with albuterol.

Information regarding FDA's approval of these inhalers is available here. As FDA approves new non-CFC inhalers, we will add that information to this page.

Drugs are listed in alphabetical order by active moiety, with specific brands available listed under each active moiety. What is an active moiety? An active moiety is the part of a drug that makes the drug work the way it does. Many different drug products may be marketed with the same active moiety.

Each drug name in the list below is linked to the drug’s regulatory history, including label, from Drugs@FDA.

 

Resources For You

Back to Top